Samsung Biologics Faces First General Strike as Labor-Management Talks Stall
Diplomacy

Samsung Biologics Faces First General Strike as Labor-Management Talks Stall

Samsung Biologics, the biotech arm of Samsung Group, continues its first-ever general strike for a fifth day. Unionized workers are demanding significant wage hikes and performance incentives, while management's counter-proposal remains insufficient. With previous partial strikes causing substantial financial losses, the impasse continues.

This article requires PRO

This article is outside the free access window or is a special report. PRO unlocks it and the full archive.